Clinical Trials

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT01310855 2017-05-31

Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma

Phase 2 Terminated

38 enrolled 8 charts

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT00085566 2016-01-20

Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer

Phase 1/2 Completed

61 enrolled 8 charts

CNSGenitourinarySarcoma

Brain Neoplasms, Glioblastoma, Prostatic Neoplasms, Central Nervous System Neoplasms, Gliosarcoma

NCT02338011 2015-01-26

EGFR

Phase 2/3 Unknown

210 enrolled

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT00042991 2014-05-28

Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas

Phase 1/2 Completed

69 enrolled 27 charts

Untreated Childhood Anaplastic Astrocytoma

NCT01363557 2014-05-13

ARPEGE

Phase NA Terminated

1 enrolled

Brain Neoplasms, Lung Neoplasms

NCT00014170 2013-07-16

Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

92 enrolled

Glioblastoma, Gliosarcoma

NCT00016991 2013-06-20

ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse

CNSEndocrineHead & NeckThoracic

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00068497 2013-01-14

Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer

Phase NA Completed

40 enrolled

Squamous Cell Carcinoma of Head and Neck, Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Parathyroid Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms, Tongue Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory, Thyroid Carcinoma, Anaplastic

NCT00238251 2012-06-05

Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases

59 enrolled

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT00132158 2012-04-17

ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors

Phase 1 Completed

19 enrolled

Glioblastoma, Neuroblastoma, Rhabdomyosarcoma, Osteosarcoma

NCT00238797 2011-01-21

A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme

36 enrolled

CNS

Brain Neoplasms, Glioblastoma

NCT01158170 2010-07-08

Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001)

Phase 3 Unknown

200 enrolled

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT00234442 2009-06-30

Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer

Phase 2 Terminated

47 enrolled

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT00135135 2008-06-03

Therapy for Children With Neuroblastoma

23 enrolled

CNS

Neoplasms, Neuroblastoma

NCT00614809 2008-02-22

Efficacy of Gefitinib for Brain Metastasis of Non-Small Cell Lung Cancer

Phase 2 Unknown

45 enrolled